Adam A Cohen (Adam Cohen, Adam F Cohen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 36

Top Topics

Hepatitis C Virus Infection

Total Knee Arthroplasty

Muscular Dystrophy

Top Venues

British journal of clinical pharmacology

JMIR formative research

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Andriy A Gorbenko, Adam A Cohen
On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long COVID. British journal of clinical pharmacology (2024)
Ahnjili Zhuparris, Ghobad Maleki, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Wessel Kraaij, Adam A Cohen, Emilie M J van Brummelen, Joris H De Maeyer, Geert Jan Groeneveld
Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study. JMIR formative research 7 (2023)
Ahnjili Zhuparris, Ghobad Maleki, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Wessel Kraaij, Adam A Cohen, Emilie M J van Brummelen, Joris H De Maeyer, Geert Jan Groeneveld
Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study. JMIR formative research 7 (2023)
Nicholas A White, Timo J C Oude Vrielink, Koen E A van der Bogt, Adam A Cohen, Joris I Rotmans, Tim Horeman
Question-based development of high-risk medical devices: A proposal for a structured design and review process. British journal of clinical pharmacology (2023)
Jeffrey K Aronson, Geoffrey T Tucker, Jeffrey K Aronson, James M Ritter, Adam A Cohen
The British Journal of Clinical Pharmacology: The first 50 years. British journal of clinical pharmacology 90 (1) (2023)
Nicholas A White, Timo J C Oude Vrielink, Koen E A van der Bogt, Adam A Cohen, Joris I Rotmans, Tim Horeman
Question-based development of high-risk medical devices: A proposal for a structured design and review process. British journal of clinical pharmacology (2023)
Jeffrey K Aronson, Geoffrey T Tucker, Jeffrey K Aronson, James M Ritter, Adam A Cohen
The British Journal of Clinical Pharmacology: The first 50 years. British journal of clinical pharmacology 90 (1) (2023)
Nicholas A White, Timo J C Oude Vrielink, Koen E A van der Bogt, Adam A Cohen, Joris I Rotmans, Tim Horeman
Question-based development of high-risk medical devices: A proposal for a structured design and review process. British journal of clinical pharmacology (2023)
Marcus P J van Diemen, Dimitrios Ziagkos, Matthijs D Kruizinga, Menno R Bénard, Philip Lambrechtse, Joris A J Jansen, Barbara A M Snoeker, Maaike G J Gademan, Adam A Cohen, Rob R G H H Nelissen, Geert Jan Groeneveld
Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty. Clinical and translational science (2022)
Ghobad Maleki, Ahnjili Zhuparris, Ingrid W Koopmans, Robert-Jan Doll, Nicoline B M Voet, Adam A Cohen, Emilie M J van Brummelen, Geert Jan Groeneveld, Joris H De Maeyer
Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study. JMIR formative research 6 (9) (2022)
Gerardus J Hassing, Michiel Joost van Esdonk, Gerard J P van Westen, Adam A Cohen, Jacobus Burggraaf, Pim Gal
Dose escalations in phase I studies: Feasibility of interpreting blinded pharmacodynamic data. British journal of clinical pharmacology 88 (12) (2022)
Adam A Cohen
Preparation for the next pandemic-A plea for a nationalized approach. British journal of clinical pharmacology (2021)
Emma F Magavern, Jan Piasecki, Adam A Cohen, Jeffrey K Aronson
Ethics in clinical pharmacology: Facilitating public trust. British journal of clinical pharmacology (2021)
Adam A Cohen, Rebecca Ultee, Glenn van Veldhoven
Making pharmaceutical companies report what matters about innovation. British journal of clinical pharmacology (2021)
Amadou Samb, Matthijs D Kruizinga, Younes Tallahi, Michiel Joost van Esdonk, Willemijn van Heel, Gertjan Driessen, Yuma Bijleveld, Frederik E Stuurman, Adam A Cohen, Anton van Kaam, Timo R de Haan, Ron Mathôt
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study. British journal of clinical pharmacology (2021)
Matthijs D Kruizinga, Rob G J A Zuiker, Kirsten R Bergmann, Annelies C Egas, Adam A Cohen, Gijs W E Santen, Michiel Joost van Esdonk
Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations. British journal of clinical pharmacology (2021)
Johan L van der Plas, Michiel J van Esdonk, Ingrid M C Kamerling, Adam A Cohen
Accelerating vaccine trial conduct in a pandemic with a hot spot-based inclusion strategy using trial and epidemic simulation. Clinical and translational science 14 (6) (2021)
Jonas M den Heijer, Jules A A C Heuberger, Hemme Hijma, Annelieke C Kruithof, Jeroen van Smeden, Geert Jan Groeneveld, Jacobus Burggraaf, Adam A Cohen
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines. British journal of clinical pharmacology (2021)
Adam A Cohen, Jan C van Meurs
Clinical ophtalmo-pharmacology. Looking ahead. British journal of clinical pharmacology 87 (9) (2021)
Jules A A C Heuberger, April Henning, Adam A Cohen, Bengt Kayser
Dealing with doping. A plea for better science, governance and education. British journal of clinical pharmacology (2021)
Matthijs D Kruizinga, Willem A J Birkhoff, Michiel Joost van Esdonk, Naomi B Klarenbeek, Tomasz Cholewinski, Tessa Nelemans, Melloney J Dröge, Adam A Cohen, Rob G J A Zuiker
Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis. British journal of clinical pharmacology 86 (1) (2020)
Johan L van der Plas, Meta Roestenberg, Adam A Cohen, Ingrid M C Kamerling
How to expedite early-phase SARS-CoV-2 vaccine trials in pandemic setting-A practical perspective. British journal of clinical pharmacology 87 (5) (2020)
Adam A Cohen
On authorship in the BJCP. British journal of clinical pharmacology 83 (10) (2019)
Jules A A C Heuberger, Sven C van Dijkman, Adam A Cohen
Futility of current urine salbutamol doping control. British journal of clinical pharmacology 84 (8) (2018)
Philip Lambrechtse, Victoria C Ziesenitz, Adam A Cohen, Johannes N van den Anker, Ernst Jan Bos
How reliable are commercially available trackers in detecting daytime sleep. British journal of clinical pharmacology 84 (3) (2018)
Ricardo Alvarez-Jimenez, Ellen P Hart, Samantha Prins, Marieke de Kam, Joop M A Van Gerven, Adam A Cohen, Geert Jan Groeneveld
Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses. British journal of clinical pharmacology 84 (5) (2018)
Adam A Cohen, Smita Pattanaik, Praveen Kumar, Robert R Bies, Anthonius de Boer, Albert Ferro, Annette Gilchrist, Geoffrey K Isbister, Sarah Ross, Andrew J Webb
Organised crime against the academic peer review system. British journal of clinical pharmacology 81 (6) (2018)
Joop M A Van Gerven, Adam A Cohen
Integrating data from the Investigational Medicinal Product Dossier/investigator's brochure. A new tool for translational integration of preclinical effects. British journal of clinical pharmacology 84 (7) (2018)
Adam A Cohen, Sergio Bonini
Annotated guidance to the European Medicines Agency (EMA) guidelines and regulatory documents. A new series of the BJCP. British journal of clinical pharmacology 84 (7) (2018)
Xia Chen, Freerk Broeyer, Marieke de Kam, Joke Baas, Adam A Cohen, Joop van Gerven
Pharmacodynamic response profiles of anxiolytic and sedative drugs. British journal of clinical pharmacology 83 (5) (2017)
Cornelis A van den Bogert, Adam A Cohen, Hubert G M Leufkens, Joop M A van Gerven
Pharmacological vs. classical approaches in the design of first in man clinical drug trials. British journal of clinical pharmacology 83 (12) (2017)
Marleen H M Hessel, Adam A Cohen, Robert Rissmann
Sofosbuvir and daclatasvir. British journal of clinical pharmacology 82 (3) (2016)
Robert Rissmann, Marleen H M Hessel, Adam A Cohen
Vemurafenib/dabrafenib and trametinib. British journal of clinical pharmacology 80 (4) (2015)
Sebastiaan Camiel Goulooze, Adam A Cohen, Robert Rissmann
Lomitapide. British journal of clinical pharmacology 80 (2) (2015)
Sebastiaan Camiel Goulooze, Adam A Cohen, Robert Rissmann
Mirabegron. British journal of clinical pharmacology 80 (4) (2015)
Sebastiaan Camiel Goulooze, Adam A Cohen, Robert Rissmann
Bedaquiline. British journal of clinical pharmacology 80 (2) (2015)